RecruitingNCT03192774
The Prospective Segeberg TAVI Registry
A Prospective Follow-up Assessment of Transcatheter Aortic Valve Implantation in Bad Segeberg
Sponsor
Segeberger Kliniken GmbH
Enrollment
2,000 participants
Start Date
Sep 1, 2007
Study Type
OBSERVATIONAL
Conditions
Summary
A single center registry including all patients treated with TAVI at the Heart Center, Bad Segeberg, Germany
Eligibility
Min Age: 18 YearsMax Age: 100 Years
Inclusion Criteria1
- All patients treated with TAVI
Exclusion Criteria1
- None
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DEVICETranscatheter Aortic Valve Implantation
Interventional replacement of the aortic valve
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03192774
Related Trials
REdo Transcatheter Aortic VALVE Implantation for the Management of Transcatheter Aortic Valve Failure
NCT0655779861 locations
MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
NCT0548761213 locations
Valve Hemodynamic Optimization Based on Doppler-Echocardiography vs Catheterization Measurements Following ViV TAVR
NCT054592337 locations
Valve Performance of the SAPIEN 3 Ultra RESILIA Valve: A Prospective Registry With Central Echocardiography Analysis.
NCT064208301 location
Post-Dilatation Effect on TAVI Prostheses Expansion
NCT074770021 location